Effect of Nimbadi Ghrita Lepam and Nimbadi Capsule in Vipadika (Palmoplantar Psoriasis)

Single Arm Open Label Clincal Trial of Nimbadi Ghrita Lepam and Nimbadi Capsule in Vipadika (Palmoplantar Psoriasis) - Nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/02/104433

Enrollment

Registered

2026-02-20

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L409- Psoriasis, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age group between 18 to 60 years. 2. Patients with signs and symptoms of vipadika (palmoplantar psoriasis). 3. Patients will be selected irrespective of their gender, religion, occupation. 4. Patients willing to participate in the study, who give written consent.

Exclusion criteria

Exclusion criteria: 1. Pregnant, lactating women. 2. Patient suffering with severe systemic diseases like diabetes, cancer, guttate psoriasis, psoriasis present on the areas other than palms and feet, systemic infections like HIV, etc.

Design outcomes

Primary

Measure	Time frame
Nimbadi Grita Lepam and Nimbadi Capsule is Effective in Vipadika (Palmoplantar Psoiasis)Timepoint: 7th, 14th, 21th, 28th Days	—

Secondary

Measure	Time frame
Reduction in PPASI Score, VAS Score. Improvement in DLQI. Timepoint: After 28 days	—

Countries

India

Contacts

Public ContactDr Rupali Ramadas Patil

Hon Shri Annasaheb Dange Ayurved Medical College and Post Graduate Research Center Ashta

rupalipatil@adamc.ac.in9225633321

Outcome results